Abstract: To provide a functional continuous rapid freezing apparatus with which cold air is made uniformly contact with the whole face of an article to be frozen, easily and rapidly passing the maximum ice crystal generating zone, and the central portion of the article to be frozen can reach for the predetermined temperature within a short period of time, a freezing chamber 2 in which an article Q to be frozen is stored, a heat exchanger 1 for cooling disposed on a central portion of the freezing chamber 2 as a partition to divide the freezing chamber 2 into a first freezing block 2a and a second freezing block 2b, a first blowing fan 5 disposed to face the heat exchanger 1 for cooling through the first freezing block 2a, and a second blowing fan 6 disposed to face the heat exchanger 1 for cooling through the second freezing block 2b, are provided.

Abstract: To provide a functional continuous rapid freezing apparatus with which cold air is made uniformly contact with the whole face of an article to be frozen, easily and rapidly passing the maximum ice crystal generating zone, and the central portion of the article to be frozen can reach for the predetermined temperature within a short period of time, a freezing chamber 2 in which an article Q to be frozen is stored, a heat exchanger 1 for cooling disposed on a central portion of the freezing chamber 2 as a partition to divide the freezing chamber 2 into a first freezing block 2a and a second freezing block 2b, a first blowing fan 5 disposed to face the heat exchanger 1 for cooling through the first freezing block 2a, and a second blowing fan 6 disposed to face the heat exchanger 1 for cooling through the second freezing block 2b, are provided.

Abstract: To provide an air-conditioning apparatus and an air-conditioning method with which air can be highly sterilized and cleaned not only in houses, but also in various facilities such as offices and factories, and, safe, pleasant, and healthy living space can be obtained, in a functional air-conditioning apparatus utilizing ground heat provided with a flow piping P which sucks air A in a room R or outside S from a suction opening Pa, sends the air A into ground G to make the air A heat-exchanged with the ground G, and blows the heat-exchanged air A into the room R through a blow opening Pb; the flow piping P is provided with a reciprocating pipe 10 for heat exchange having a going portion 11 to send the air A into the ground G and a returning portion 12 to return the air A heat-exchanged with ground heat under the ground, and a sterilizer 2. In which disinfectant liquid W is reserved, is disposed between the blow opening Pb and a ground exhaust opening 10b of the reciprocating pipe 10 for heat exchange.

Abstract: The invention relates to a versatile disinfectant containing as main components, a metal ion having an antimicrobial action, L-cysteine and L-ascorbic acid, characterized in that it contains a surfactant excluding a nonionic surfactant in addition to these main components. The versatile disinfectant may further contain one or more compounds selected from the group consisting of sorbic acid, sorbates, benzoic acid, benzoates and p-hydroxybenzoate esters. The pH of the versatile disinfectant is preferably adjusted to 2.5 to 4.0. The disinfectant can disinfect an object to be treated for an environment, an apparatus, a human body, an animal body, a plant body, an organic matter or the like by bringing the disinfectant into contact with such an object to be treated.

Abstract: There has been effort to develop a lactobacillus that would be useful as a probiotic, and to develop a lactobacillus which would colonize and proliferate in lesions of infection, eliminating the causal bacteria. This problem was resolved by developing a Lactobacillus casei species having the following key properties. (1) The species can be grown in the presence of any of one to four amino acids as a nitrogen source necessary for growth. (2) When a growth-promoting culture medium is inoculated with the species and Escherichia coli in the same count and subjected to anaerobic mixed culturing at 37° C., the final count of lactobacilli is 50% or more of the coliform count. (3) Upon cultivation in an appropriate culture medium, the final pH value is 4.0 or below, and the highest acidity is 1.5% or more. (4) The species is resistant to 5% bile salts. (5) The species produces an antibiotic.

Abstract: A method for treating periodontal disease by first disinfecting the affected part with a bactericidal disinfectant containing ferric ions (Fe+3) and L-ascorbic acid as the principal components and one or more of sorbic acid, benzoic acid and para-hydroxybenzoic acid esters, and then injecting a preparation containing a Lactobacillus casei into the affected part. Antibiotics are contained in the preparation, for enhancing the therapeutic effects.

Abstract: There has been effort to develop a lactobacillus that would be useful as a probiotic, and to develop a lactobacillus which would colonize and proliferate in lesions of infection, eliminating the causal bacteria. This problem was resolved by developing a Lactobacillus casei species having the following key properties. (1) The species can be grown in the presence of any of one to four amino acids as a nitrogen source necessary for growth. (2) When a growth-promoting culture medium is inoculated with the species and Escherichia coli in the same count and subjected to anaerobic mixed culturing at 37° C., the final count of lactobacilli is 50% or more of the coliform count. (3) Upon cultivation in an appropriate culture medium, the final pH value is 4.0 or below, and the highest acidity is 1.5% or more. (4) The species is resistant to 5% bile salts. (5) The species produces an antibiotic.

Abstract: A method for treating periodontal disease by first disinfecting the affected part with a bactericidal disinfectant containing ferric ions (Fe3+) and L-ascorbic acid as the principal components and one or more members of the group consisting of sorbic acid, benzoic acid and para-hydroxybenzoic acid esters, and then injecting a preparation containing a novel Lactobacillus casei into the affected part, wherein antibiotics are contained in the preparation, for enhancing the therapeutic effects.

Abstract: The culture and preservation of Lactobacillus clearans require special considerations because the titer readily decreases. There is thus an urgent need for culture media and preservatives to prevent such a decrease in bacterial titer during both subculture and storage. The present invention relates to a culture medium in which at least one or more of sodium sulfide and ammonia is decreased by Lactobacillus clearans during culture with the addition of at least one or more of sodium sulfide and aqueous ammonia, as well as to a method for preserving Lactobacillus clearans in which at least one or more of a sulfur-containing amino acid, ovalbumin, bile powder, trehalose, raffinose, dead yeast cells, chlorella, rice bran, bran, soybean milk, and carrot juice is or are present as a preservative around the bacteria.

Abstract: Although the inventors previously found that the novel species designated Lactobacillus clearans was highly effective for health purposes, they noted in particular that this species lacked sufficient intestinal purification action. Efforts to produce a species of higher potency and the like to remedy this drawback led to the unavoidable conclusion that the use of a bacterium by itself produced limited results. The concurrent use of another active substance was thus considered in seeking a lactic acid bacteria preparation capable of invigorating healthy individuals, and of renewing a sense of well being and restored health in semi-sick individuals or semi-healthy individuals. The invention relates to a lactic acid bacteria preparation, comprising viable cells of Lactobacillus clearans, and either or both of viable and killed cells of Enterococcus faecalis capable of reducing one or more of at least triglycerides and cholesterol.

Abstract: Pathogenic bacteria have long posed a threat to mankind, and it has been a goal in the food industry and the medical profession to develop a bactericide that would have a high degree of practicality which included spores in its scope, that would exhibit a pronounced effect on pathogenic bacteria, that would be safe for humans and the earth, and that would be composed of metal ions having affinity with the body, that is, those which are essential structural components for the body, and compounds that are used in food additives. Provided are a bactericide containing ferric ions (Fe3+) and one or more members of the group consisting of sorbic acid, benzoic acid, and para-hydroxybenzoic acid esters; a bactericide containing ferric ions (Fe3+), L-ascorbic acid, and one or more members of the group consisting of sorbic acid, benzoic acid, and para-hydroxybenzoic acid esters; and a bactericide containing ferric ions (Fe3+), sorbic acid, benzoic acid, and L-ascorbic acid.

Abstract: A biodeodorizer and a process to prepare the biodeodorizer which comprises (a) at least one strain selected from the group consisting of Lactobacillus deodorans, Lactobacillus clearans and a mixed strain of Lactobacillus sulfurica and Lactobacillus nitrosus, and (b) Streptococcus faecalis having the ability to produce antibiotics.

Abstract: A novel Lactobacillus clearans, Lactobacillus sulfurica and Lactobacillus nitrosus:which can decrease both Na.sub.2 S.9H.sub.2 O and/or NH.sub.3 when inoculated and cultured on:a medium comprising 5 g of meat extract, 5 g of peptone, 0.5 g of Na.sub.2 S.9H.sub.2 O, 5 g of glucose, 1 g of CaCO.sub.3, 0.5 ml of NH.sub.3 (as 100% ammonia) and 1 liter of water (pH, neutral);which shows no growth acceleration action even when said bacteria is cultured on a medium comprising a Stephenson-Wetham medium (hereafter merely referred to as (S-W); KH.sub.2 PO.sub.4 1 g, MgSO.sub.4.7H.sub.2 O 0.7 g, NaCl 1 g, (NH.sub.4).sub.2 HPO.sub.4 4 g; FeSO.sub.4.7H.sub.2 O 0.03 g, glucose 5 g)+vitamins (A: 900 IU, B.sub.1 : 1 mg, B.sub.2 : 1 mg, B.sub.6 : 1 mg, B.sub.12 : 5 gamma nicotinamide: 1.6 mg, calcium pantothenate: 8 mg, C: 64 mg, D.sub.2 : 120 IU)+casamino acid 1 g and 0.5 g of Na.sub.2 S.9H.sub.2 O and/or 0.5 ml (100% conversion) of NH.sub.

Abstract: This invention comprising a single or plural strains of Lactobacillus having special characteristics that have been never known is a new type of pharmaceutical Lactobacillus preparation for the treatment of infectious diseases.Some of the characteristics of Lactobacillus used for the present invention as as follows.(a) They are able to grow in low nutrition.(b) The speed of multiplication is quick.(c) By odoriferous S--, N-- & C--compound, is promoted the growth.The effects of the present invention are as follows.